Primary Outcome Measures:
- SF-12v2 [ Time Frame: Up to 24 months post-op ] [ Designated as safety issue: No ]
- EQ-5D [ Time Frame: Up to 24 months post-op ] [ Designated as safety issue: No ]
- SMFA [ Time Frame: Up to 24 months post-op ] [ Designated as safety issue: No ]
- Knee Society Score [ Time Frame: Up to 24 months post op ] [ Designated as safety issue: No ]
- Clinical Assessment [ Time Frame: Up to 24 months post-op ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Re-operation (secondary procedures) [ Time Frame: Up to 24 months post-op ] [ Designated as safety issue: Yes ]
- nonunion [ Time Frame: Until radiographically healed ] [ Designated as safety issue: Yes ]
- superficial infection rates (wound only) [ Time Frame: Up to 24 months post-op ] [ Designated as safety issue: Yes ]
- deep infection (bone implant interface) [ Time Frame: Up to 24 months post-op ] [ Designated as safety issue: Yes ]
- compartment syndrome [ Time Frame: Up to 24 months post-op ] [ Designated as safety issue: Yes ]
- malunion (>5 degrees varus/valgus) [ Time Frame: Up until radiographically healed ] [ Designated as safety issue: Yes ]
- >5 degrees anterior or posterior angulation [ Time Frame: Up until radiographically healed ] [ Designated as safety issue: Yes ]
- >10 malrotation degrees, and >1cm shortening) [ Time Frame: Up until radiographically healed ] [ Designated as safety issue: Yes ]
- knee range of motion [ Time Frame: Up to 24 months post-op ] [ Designated as safety issue: Yes ]
The study is a randomized controlled multicenter trial in which individuals sustaining a fracture of the supracondylar (metaphyseal) region of the distal femur will be operatively managed by one of two strategies. The first strategy involves fixation of the fracture with a reamed, interlocking intramedullary nail (Nail Group). The second treatment strategy involves open reduction and internal fixation of the fracture with a locking periarticular plate (Plate Group). The null hypothesis of the study is that there will be no difference in the two groups with respect to the primary and secondary outcome measures. To the degree possible, patients in the two groups will receive post-operative care according to the same standards and protocols.